Strategic Analysis of Global Scientific Business Intelligence (Sci-BI) in Pharmaceutical and Biotechnology Markets
Strategic Analysis of Global Scientific Business Intelligence (Sci-BI) in Pharmaceutical and Biotechnology Markets
RELEASE DATE
30-Dec-2008
30-Dec-2008
REGION
North America
North America
Research Code: N532-01-00-00-00
SKU: HC02109-NA-MR_07583
$4,950.00
In stock
SKU
HC02109-NA-MR_07583
Description
This strategic analysis identifies the current trends in scientific business intelligence (Sci-BI) in pharmaceutical and biotechnology markets. Major global healthcare trends are analyzed and the impacts on Sci-BI are delineated. A close look at drivers and restraints in the Sci-BI space revealed interesting growth stimulators while also identifying critical road blocks in the growth of the Sci-BI market. A step by step analysis of the R&D cost distribution in pharma/biotech was carried out together with a competitive landscape analysis of the different players in this niche market segment.
Table of Contents
Title Page
- Title Page
Disclaimer
- Disclaimer
Certification
- Certification
Table of Contents
- Table of Contents
Notes on Methodology
- Notes on Methodology
Introduction
Segmentation
Major Global Healthcare Trends
Current Industry Trends in Sci-BI
Overall Market Drivers and Restraints
Sci-BI Drivers
Sci-BI Restraints
Opportunity Analysis – Major Areas of Convergence
Opportunity Analysis: Growth Drivers for Sci-BI & Workflow Management
The ROI Challenge for Pharma
Pharmaceutical R&D Expenditure
End to End Sci-BI Services
Sci-BI Markets: Competitive Landscape
Challenges & Conclusions
Popular Topics
This strategic analysis identifies the current trends in scientific business intelligence (Sci-BI) in pharmaceutical and biotechnology markets. Major global healthcare trends are analyzed and the impacts on Sci-BI are delineated. A close look at drivers and restraints in the Sci-BI space revealed interesting growth stimulators while also identifying critical road blocks in the growth of the Sci-BI market. A step by step analysis of the R&D cost distribution in pharma/biotech was carried out together with a competitive landscape analysis of the different players in this niche market segment.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | N532-01-00-00-00 |
Is Prebook | No |